FDA Inspection 552585 — Shaanxi Hanjiang Pharmaceutical Group Co., Ltd (Gaoxin site)
The FDA completed an inspection of Shaanxi Hanjiang Pharmaceutical Group Co., Ltd (Gaoxin site) on November 21, 2008 in Hanzhong. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- November 21, 2008
- Fiscal Year
- 2009
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Hanzhong (China)